By Bridget Hagen August 19, 2025 Two members of Cornell’s business incubators have been accepted to Cohort 2025 of the…
Two Cornell graduates, CEOs of Praxis clients REEgen and Soctera, benefit from the vibrant innovation ecosystem at Cornell and Activate’s…
Ithaca – On March 21, 2019 at 5:00 pm, Cornell University will host a grand opening and ribbon cutting for…
More Center News
Soctera, a client of Cornell's Praxis Center for Venture Development, is preparing to bring its next-generation radio frequency amplifier technology to…
The Cornell research team behind Soctera, a startup developing a more efficient power amplifier, has achieved a breakthrough in their…
Exostellar, a startup born from Cornell research, has achieved an outcome many entrepreneurs dream of – acquisition by a Fortune…
OWiC Technologies is developing tiny generators for large-scale drug discovery The Cornell spinout OWiC Technologies is developing smart chips that…
Soctera Inc, a Praxis member company and a startup funded by America’s Seed Fund powered by the U.S. National Science Foundation,…
More Client News
Cornell physics researchers have developed a new framework for studying how biomolecular condensates form and dissolve in cells.
A genetically engineered bacterium can rapidly break down one of Earth’s most abundant minerals, opening a promising new pathway for removing CO2 from the atmosphere and recovering critical elements, according to new Cornell research.
A company founded by a Cornell doctoral alum is using microneedle technology to create a pain-free tattoo experience.
The 3,681 first-year students and 603 transfers who begin moving to campus Aug. 17, hail from 49 states plus Washington, D.C., Puerto Rico and American Samoa, and 62 countries.
Using a photochemically driven labeling technique, a Cornell-led research group has devised a way to capture cancer-specific protein-to-protein interactions, which could spawn targeted therapies for prostate and other forms of the disease.
More Cornell News
